pharmaceutical
FDA halts trial after first CAR T-associated patient death
September 6, 2017Research and Development CAR T, CAR-T, Cancer, FDA, cellectis, leukaemia, patient death, pharma, pharmaceutical
French clinical-stage biopharma firm Cellectis has received an order from the FDA to halt its study of CAR T therapy …
Novo Nordisk settles lawsuit over illegal marketing practices for $58.7 million
September 6, 2017Research and Development, Sales and Marketing FDA, Novo Nordisk, US, US Justice Department, Victoza, diabetes, pharma, pharmaceutical
Novo Nordisk has resolved a probe by the US Justice Department which accused the Danish drugmaker of illegal marketing activities …
Takeda’s Ninlaro knocked back by NICE for second time
September 5, 2017Research and Development, Sales and Marketing Ninlaro, Takeda, biotech, drugs, pharma, pharmaceutical
NICE has revealed that the outcome of its consultation process for Ninlaro (ixazomib), Takeda’s treatment for relapsed or refractory multiple …
Pfizer’s drug back on the market after proving safety
September 5, 2017Manufacturing and Production, Sales and Marketing Mylotarg, Pfizer, biotech, drugs, pharma, pharmaceutical
Back in 2000, Pfizer had a drug that was granted accelerated approval for the treatment of acute myeloid leukaemia (AML) …
Merck KGaA to streamline business with $1bn healthcare sale
September 5, 2017Manufacturing and Production, Sales and Marketing GSK, Merck KGaA, biotech, drugs, pharma, pharmaceutical
Merck KGaA has revealed that it is looking to sell its consumer healthcare business, in order to refocus the business …
Patently problematic? The impact of the Eli Lilly/Actavis intellectual property battle
September 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Eli Lilly, biotech, drugs, pemetrexed, pharma, pharmaceutical
The UK Supreme Court has sent shockwaves through the intellectual property world with its recent decision on Eli Lilly v …
NHS needs emergency £350 million to survive winter
September 4, 2017Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical
NHS Providers has stated that £350 million needs to be injected into the NHS to avoid the ‘humanitarian crisis’ that …
Sanofi backs out of controversial Zika vaccine project
September 4, 2017Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical
Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …
Top Ten most popular articles on Pharmafile.com this week
September 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Trump, drugs, health, life sciences, medicine, pharma, pharmaceutical, top ten
This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …
R&D tax credits: A novel approach to supply chain funding
September 1, 2017Manufacturing and Production, Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, tax credits
Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of HMRC’s R&D Consultative Committee, says R&D tax credits …
NICE rejects AstraZeneca’s breast cancer drug Faslodex
September 1, 2017Medical Communications, Sales and Marketing AstraZeneca, Cancer, Faslodex, breast cancer, life sciences, pharma, pharmaceutical
NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …
NHS pumps £100m into GP recruitment as numbers plummet
September 1, 2017Medical Communications GP, NHS, biotech, drugs, pharma, pharmaceutical
The NHS has been forced to offer £100 million to recruitment agencies in order to plug growing gaps in the …
FDA approves treatment to counter CAR-T side-effects
August 31, 2017Medical Communications, Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical
On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …
Lilly gets second shot at application for ‘blockbuster’ arthritis drug
August 31, 2017Sales and Marketing Eli Lilly, arthritis, baricitinib, biotech, drugs, pharma, pharmaceutical
Earlier this year, Eli Lilly was on the receiving end of one of the most surprising setbacks in recent times …
CAR-T treatment is given ‘historic’ first approval by FDA
August 31, 2017Research and Development, Sales and Marketing CAR-T, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical
Novartis has received approval for its CAR-T treatment of paediatric and young adults with a form of acute lymphoblastic leukaemia …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
